Evidence map›Paper›PMID 29291716›Full record

ArticleBMC palliative care2018

Advance directives from haematology departments: the patient's freedom of choice and communication with families. A qualitative analysis of 35 written documents.

S Trarieux-Signol, D Bordessoule, J Ceccaldi, S Malak, A Polomeni, J B Fargeas, N Signol, H Pauliat, S Moreau

Open access · goldAbstract readMulticenter Study
In one paragraph

Article in BMC palliative care, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.8field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 21 citations in OpenAlex.

  1. Trial
  2. Article
  3. Content analysis of Advance Directives completed by patients with advanced cancer as part of an Advance Care Planning intervention: insights gained from the ACTION trial.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2020
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 1 country.

S Trarieux-SignolHaematology and cellular therapy Department, CHU Limoges, 2 avenue Martin Luther King, 87000, Limoges, France. sophie.trarieux@chu-limoges.fr.ORCID http://orcid.org/0000-0001-5205-1721
D BordessouleHaematology and cellular therapy Department, CHU Limoges, 2 avenue Martin Luther King, 87000, Limoges, France.
J CeccaldiLibourne Hospital, 112, rue de la Marne BP 199, 33505, Libourne, Cedex, France.
S MalakCurie Institute, 26 Rue d'Ulm, 75005, Paris, France.
A PolomeniSaint Antoine Hospital, 184 Rue du Faubourg Saint-Antoine, 75012, Paris, France.
J B FargeasSaint Yrieix la Perche Hospital, Place du Président Magnaud, 87500, Saint Yrieix la Perche, France.
N SignolSaint-Junien Hospital, 12, rue de Châteaubriand, 87205, Saint-Junien, France.
H PauliatObservatory of Institutional and Legal Changes (OMIJ), Faculty of Law and Economics, 5 rue Félix Éboué, B.P. 3127, 87031, Limoges, Cedex 1, France.
S MoreauHaematology and cellular therapy Department, CHU Limoges, 2 avenue Martin Luther King, 87000, Limoges, France.
Centre Hospitalier Universitaire de Limoges · FRInstitut Curie · FRSorbonne Université · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn France, advance directives are favourably perceived by most of the population, although the drafting rate is low. This ambivalence is challenging because advance directives are meant to promote the autonomy and freedom of choice of patients. The purpose of this study was to analyse the content of advance directives written by patients suffering from malignant haemopathies to better understand how patients put them into practice. These could be relevant as early as the initial diagnosis of haematological malignancies because of the uncertain course of the disease.

methodsThis was a multicentre, qualitative, descriptive study. The advance directives written by patients with malignant haemopathies treated in one of the six French hospital departments were included in the study from 01/06/2008 to 15/04/2016. A thematic analysis of the advance directives was performed by two researchers: a senior haematologist and a research assistant.

resultsThe median age of the patients was 69. Most were women (sex ratio: 0.59), living as a couple (57%), with lymphoid pathologies (66%), who were still alive two years after the instructions were written (63%) and had nominated a health care proxy (88.6%). Free texts (62.9%) were richer in content than pre-defined forms. The advance directives were used in three ways: for a purely legal purpose, to focus on medical treatments or actions, or to communicate a message to the family. Three main themes emerged: (1) refusal of medical treatment (100%), in which patients express refusal of life-sustaining care (97.1%). The actual treatments or the moment when they should be limited or stopped were not always mentioned in detail. (2) A desire for effective pain relief to avoid suffering (57.1%) and (3) messages for their family (34.3%), such as funeral arrangements (17.1%) and messages of love or trust (14.3%).

conclusionsPatients who write advance directives are not necessarily at the end of their lives. Their content mainly conveys treatment wishes, although patients also use them to pass on personal messages to their close family. This emerging role of advance directives to communicate messages within the family should be valued, even if it is not their original purpose.

Indexed as

Choice BehaviorAdolescentAdultAdvance DirectivesAgedAged, 80 and overCommunicationFamilyFemaleFranceHematologyHumansMaleMiddle AgedQualitative ResearchRetrospective StudiesAdvance directivesDecision makingEnd of lifeEthics of carePatient’s willQualitative research

Identifiers

PMID29291716
PMCPMC5749003
OpenAlexW2782456682

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.